
Sarah Karlin-Smith
@sarahkarlin
Covering intersection of pharma, policy & politics for @pharmapinksheet. Past @smpagwu adjunct, @politico. Inflexible Yogi, Volunteer Clown. @amaxsmith fan.
ID: 42703163
26-05-2009 19:50:18
41,41K Tweet
16,16K Followers
3,3K Following



The U.S. FDA thinking may have changed, meaning stalled programs could be revived, Pink Sheet, Citeline Regulatory's Sarah Karlin-Smith reports: US FDA Cell-Gene Therapy Head Says Agency Has Revived Stalled Programs insights.citeline.com//pink-sheet/r-…

Some MedPAC commissioners are warning the current Part D trends could lead to the end of the traditional fee-for-service Medicare without changes. Via Michael McCaughan insights.citeline.com/pink-sheet/mar…







The latest Pink Sheet, Citeline Regulatory podcast is posted! Listen as Sue Sutter, Sarah Karlin-Smith, Nielsen Hobbs and I discuss CBER Director Vinay Prasad's comments about staying out of app reviews and the cuts in the U.S. FDA budget proposal. NO PAYWALL!: insights.citeline.com/pink-sheet/pod…